Issue 48, 2008

Bacterial magnetic nanoparticles as drug carriers

Abstract

Magnet doxorubicin (DOX) drugs are efficiently produced by using bacterial magnetic nanoparticles (BMP) as anti-cancer drug carriers and dual functional cross-linkers glutaraldehyde, disuccinimidyl (DSS), N-succinimidyl 3-(2-pyridyldithio) propionate (SPDP) and di(N-succinimidyl) carbonate (DSC) as coupling reagents. Glutaraldehyde shows the highest coupling efficiency with the DOX load ratio of about 46.6%. Doxorubicin coupled bacterial magnetic nanoparticles (DBMP) disperse well in aqueous solution, exhibit a narrow size distribution with mean diameter about 70 nm and a high magnetic response with ferromagnetic properties, and show strong cytotoxicity to HePG2 and MCF-7 cancer cells.

Graphical abstract: Bacterial magnetic nanoparticles as drug carriers

Article information

Article type
Paper
Submitted
20 May 2008
Accepted
10 Sep 2008
First published
13 Nov 2008

J. Mater. Chem., 2008,18, 5993-5997

Bacterial magnetic nanoparticles as drug carriers

L. Guo, Ji Huang, X. Zhang, Y. Li and L. Zheng, J. Mater. Chem., 2008, 18, 5993 DOI: 10.1039/B808556K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements